Frank Salisbury serves as the Vice President of Commercial Strategy at PureTech Health, where he leverages over 20 years of extensive experience in the healthcare sector to drive the strategic direction of the company’s diverse portfolio of development programs. His role encompasses a broad spectrum...
Frank Salisbury serves as the Vice President of Commercial Strategy at PureTech Health, where he leverages over 20 years of extensive experience in the healthcare sector to drive the strategic direction of the company’s diverse portfolio of development programs. His role encompasses a broad spectrum of therapeutic areas, including pulmonary, central nervous system (CNS), and oncology, positioning him at the forefront of innovation in biotechnology and pharmaceuticals.
At PureTech, Frank leads the New Product Strategy function, collaborating closely with cross-functional development teams to establish the strategic framework for pipeline programs. This includes defining Target Product Profiles and making critical decisions regarding indication selection, ensuring that each product aligns with market needs and regulatory expectations. His expertise in brand leadership and sales strategy is instrumental in navigating the complexities of product launches, particularly for breakthrough therapies that have the potential to transform patient care.
Frank's track record includes the successful launch of multiple first-in-indication products, two of which received Breakthrough Therapy Designation from the FDA, underscoring his ability to drive commercial success in a competitive landscape. His strategic acumen is complemented by a deep understanding of market research and product development, allowing him to craft compelling business strategies that resonate with stakeholders across the healthcare ecosystem. As a visionary leader, Frank continues to shape the future of PureTech Health, ensuring that the company remains at the cutting edge of therapeutic innovation while delivering meaningful solutions to patients worldwide.
